James Lamar Wittliff

James Lamar Wittliff
Born(1938-06-15)June 15, 1938
Taft, Texas
EducationUniversity of Texas at Austin
(B. A., Ph. D.)
Louisiana State University School of Medicine (M. S.)
Known forCreator of original QA surveys for Cooperative Clinical Trial Groups and the CAP for estrogen & progestin receptors and Co-Developer with NEN/DuPont of First FDA approved test kits of these cancer biomarkers
Scientific career
FieldsBiochemistry & Laboratory Medicine
InstitutionsUniversity of Rochester
University of Louisville
Doctoral advisorRobert L. Airth
Notable studentsDavid G. Gardner
Elizabeth S. Boylan
de:Herbert Zech

James Lamar Wittliff (born June 15, 1938) also known as Jim Wittliff, is an American Biochemist and Professor Emeritus of Biochemistry & Molecular Genetics at the University of Louisville. He was Chairman of the Department of Biochemistry at the University of Louisville School of Medicine and Dentistry from 1976-1983. Wittliff's laboratory was designated the National Reference Facility by the National Cancer Institute for performing quality assurance surveys of receptor biomarker testing in breast cancers for cooperative clinical trial groups in the United States and Canada. He is the co-developer with NEN/DuPont of the 1st FDA approved tests for quantifying levels of estrogen and progestin receptor proteins.